Form 4: STERIS plc CFO Michael Tokich Exercises Options and Sells Shares

Michael Tokich, CFO of STERIS plc, exercised stock options and sold shares on May 15, 2024, according to a Form 4 filing with the SEC.

Summary

• On May 15, 2024, Michael J Tokich, the Senior Vice President and CFO of STERIS plc, exercised an option to purchase 32,000 ordinary shares at a price of $77.07 per share.
• Following the exercise of the option, Mr. Tokich sold a total of 32,000 shares in multiple transactions at weighted average prices ranging from $233.34 to $236.22.
• The sales resulted in the disposal of 5,039 shares at $233.34, 3,281 shares at $234.54, 17,500 shares at $235.84, and 6,180 shares at $236.22.
• After these transactions, Mr. Tokich directly owns 42,464 ordinary shares and indirectly owns 3,557 ordinary share equivalents through the STERIS Corporation 401(k) Plan.
• 11,455 of the directly owned shares are restricted and will vest at various dates between May 31, 2024, and June 2, 2026.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a standard disclosure of insider trading activity. The CFO exercised options and sold shares, which is a common practice.

Industry Context

This filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares for personal financial management. The impact on the stock price is usually minimal unless the transaction is unusually large or signals a change in the executive's confidence in the company.

Comparison to Industry Standards

• Insider trading activity is common across publicly listed companies.
• Executives often exercise stock options as part of their compensation packages and may sell shares to diversify their holdings or for personal liquidity.
• The scale of these transactions is typical for a CFO of a company the size of STERIS plc.
• Comparable companies such as Medtronic, Boston Scientific, and Abbott Laboratories also see regular Form 4 filings from their executives.

Key Dates